Apyx Medical named in securities class action over off-label product statements

Apyx Medical Corp

Plaintiff William Hattaway filed securities class action in Middle District of Florida on June 6, 2022.
Defendants: Apyx Medical, CEO Charles Goodwin, CFO Tara Semb; claims under Sections 10(b) and 20(a).
Allegations focus on public statements regarding off-label use of Advanced Energy products; class period May 12, 2021 - Mar 11, 2022.
Complaint seeks unspecified damages; company states allegations are without merit and will defend vigorously.
The complaint has not yet been served on the company.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.